European Parliament And Council Of EU "Not Far Apart" On Scrutiny Of High-Risk Devices, IVDs
This article was originally published in SRA
The provision relating to the scrutiny of high-risk products under the proposed EU regulations on medical devices and IVDs has at last made it onto the agenda of the joint talks between the European Parliament, Council of the European Union and the European Commission which were held on December 3.
You may also be interested in...
Those marketing products covered under the EU’s MDR and IVD Regulations have plenty of reading this month to help them prepare. More details have also emerged about the UK’s regulatory future.
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.